-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Initiates Coverage On Regenxbio with Outperform Rating, Announces Price Target of $22

Benzinga·10/05/2026 09:49:03
Mizuho analyst Graig Suvannavejh initiates coverage on Regenxbio (NASDAQ:RGNX) with a Outperform rating and announces Price Target of $22.